These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Recent results of irinotecan therapy in colorectal cancer]. Láng I; Hitre E Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572 [TBL] [Abstract][Full Text] [Related]
5. Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting. Folprecht G; Köhne CH Nat Clin Pract Oncol; 2005 Nov; 2(11):578-87. PubMed ID: 16270098 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy: How useful is adjuvant irinotecan in stage IV CRC? Loupakis F; Falcone A Nat Rev Clin Oncol; 2010 Apr; 7(4):190-1. PubMed ID: 20354542 [TBL] [Abstract][Full Text] [Related]
7. [A review of chemotherapy for metastatic colon cancer]. Díez-Fernández R; Salinas Hernández P; Girón-Duch C Farm Hosp; 2006; 30(6):359-69. PubMed ID: 17298193 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for colorectal cancer. Goyle S; Maraveyas A Dig Surg; 2005; 22(6):401-14. PubMed ID: 16479107 [TBL] [Abstract][Full Text] [Related]
9. [New therapeutic options in chemotherapy of advanced colorectal cancer]. Reimer P; Rückle-Lanz H Med Klin (Munich); 2001 Oct; 96(10):593-8. PubMed ID: 11715331 [TBL] [Abstract][Full Text] [Related]
10. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?]. Carnaghi C; Zucali P; Garassino I Tumori; 2000; 86(5 Suppl 2):S19-25. PubMed ID: 11195298 [TBL] [Abstract][Full Text] [Related]
11. Current status of capecitabine in the treatment of colorectal cancer. Rothenberg ML Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):16-22. PubMed ID: 12520635 [TBL] [Abstract][Full Text] [Related]
12. Irinotecan in metastatic colorectal cancer: dose intensification and combination with new agents, including biological response modifiers. Ducreux M; Köhne CH; Schwartz GK; Vanhoefer U Ann Oncol; 2003; 14 Suppl 2():ii17-23. PubMed ID: 12810453 [TBL] [Abstract][Full Text] [Related]
13. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. Hind D; Tappenden P; Tumur I; Eggington S; Sutcliffe P; Ryan A Health Technol Assess; 2008 May; 12(15):iii-ix, xi-162. PubMed ID: 18462574 [TBL] [Abstract][Full Text] [Related]
14. New developments in systemic chemotherapy in advanced colorectal cancer. Cats A Scand J Gastroenterol Suppl; 2003; (239):78-86. PubMed ID: 14743888 [TBL] [Abstract][Full Text] [Related]
15. Current and ongoing trials with irinotecan in the United States. Fuchs CS Semin Oncol; 2003 Aug; 30(4 Suppl 12):9-17. PubMed ID: 14508722 [No Abstract] [Full Text] [Related]
16. Optimizing the use of irinotecan in colorectal cancer. Cunningham D; Maroun J; Vanhoefer U; Van Cutsem E Oncologist; 2001; 6 Suppl 4():17-23. PubMed ID: 11585970 [TBL] [Abstract][Full Text] [Related]
17. Advances in the treatment of metastatic colorectal cancer. Fishman AD; Wadler S Clin Colorectal Cancer; 2001 May; 1(1):20-35. PubMed ID: 12445376 [TBL] [Abstract][Full Text] [Related]
18. Oral capecitabine: bridging the Atlantic divide in colon cancer treatment. Van Cutsem E; Verslype C; Tejpar S Semin Oncol; 2005 Feb; 32(1):43-51. PubMed ID: 15726505 [TBL] [Abstract][Full Text] [Related]
19. Update on clinical data combining capecitabine with targeted agents in newly diagnosed colorectal cancer. Lee JJ; Chu E Clin Colorectal Cancer; 2007 Dec; 7 Suppl 1():S16-20. PubMed ID: 18361802 [TBL] [Abstract][Full Text] [Related]
20. [Systemic treatment of colorectal cancers--factual standards and perspectives]. Miron L Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):752-8. PubMed ID: 14756014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]